Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
L Moreno-Fierros, I García-Silva… - Expert Opinion on …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by the SARS-CoV-2 virus is having an unprecedented
impact on global health derived from its quick spread, which is attributed to its high stability …
impact on global health derived from its quick spread, which is attributed to its high stability …
COVID-19 vaccines: implementation, limitations and opportunities
DD Richman - Global health & medicine, 2021 - jstage.jst.go.jp
The speed of development and the magnitude of efficacy of recently developed vaccines
directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize …
directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize …
[HTML][HTML] COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
The rapid scale-up of research on coronavirus disease 2019 (COVID-19) has spawned a
large number of potential vaccines and immunotherapies, accompanied by a …
large number of potential vaccines and immunotherapies, accompanied by a …
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine: preclinical studies
Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in
clinical development and 173 are in the pre-clinical phase. Five types of vaccines are …
clinical development and 173 are in the pre-clinical phase. Five types of vaccines are …
The role of vaccines in the COVID-19 pandemic: what have we learned?
F Krammer - Seminars in Immunopathology, 2024 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 and
caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed …
caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed …
Antibody responses to SARS-CoV-2: let's stick to known knowns
The scale of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
has thrust immunology into the public spotlight in unprecedented ways. In this article, which …
has thrust immunology into the public spotlight in unprecedented ways. In this article, which …
Immunity elicited by natural infection or Ad26. COV2. S vaccination protects hamsters against SARS-CoV-2 variants of concern
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have
emerged and may pose a threat to both the efficacy of vaccines based on the original …
emerged and may pose a threat to both the efficacy of vaccines based on the original …
Boosting immunity to COVID-19 vaccines
JA Juno, AK Wheatley - Nature medicine, 2021 - nature.com
Boosting immunity to COVID-19 vaccines | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
SARS-CoV-2 vaccines: Lights and shadows
Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit
an immune neutralizing response. Some concerns have been raised regarding the safety of …
an immune neutralizing response. Some concerns have been raised regarding the safety of …